Project
I6T-MC-AMBG
Automatically Closed · 2018 until 2021
Brand Stephan, Sulz Michael, Krieger-Grübel Claudia, Smolders Jolijn
Type
Clinical Studies
Range
Multicentric, KSSG as participating partner
Units
Status
Automatically Closed
Start Date
2018
End Date
2021
Financing
Industry
Brief description/objective
A Phase 3, Multicenter, Randomized, Double-Blind, Parallel-Arm, Placebo-Controlled Maintenance Study of Mirikizumab in Patients with Moderately to Severely Active Ulcerative Colitis LUCENT 2